Biomaterials science and biomedical engineering have sustained as one among frontier and growing areas of research and innovation within the engineering science community in the world; considering the number of scientific discoveries and their societal impact. Significant attempts were largely directed to re-create functional musculoskeletal systems with considerable potential to treat various types of human diseases. At the beginning of my presentation, I will present multiscale measurements and analysis to quantitatively understand the process physics of binderjet 3D printing. I will present some of our recent results to demonstrate the efficacy of the 3D powder printing to fabricate Sr-substituted Mg-phosphate bioceramic scaffolds and Zirconia bioceramics, albeit with specific challenges. A major emphasis will be placed on the binder formulation, post-processing treatment, and micro-computed tomography of interconnected porous architecture together with the strength reliability. One of the most recent clinical translational attempts to treat decompressive craniectomy using 3D powder printed patient-specific cranial prosthesis will be presented. Towards the end, the recent results of 3D bioprinting will be presented. It will be shown as how the hydrothermally synthesized nanocrystalline needle-shaped HAp particles (<30 nm) were incorporated into pre-crosslinked gelatin methacryloyl (GelMA) hydrogel to obtain a better combination of compression strength (~ 300 kPa) and elastic modulus (~ 300 kPa) in a designed scaffold. We propose that the inorganic-organic nanocomposite hydrogel could be efficiently assembled to formulate a potential bioink for 3D bioprinting applications towards bone tissue regeneration. This lecture will close by introducing a new concept, Biomaterialomics, which brings together Biomaterials science and Data Science.
Coming soon.
Coming soon.
Coming soon.
Coming soon.
In the realm of tissue engineering, 3D bioprinting stands out as a revolutionary technology with immense potential. By allowing precise printing and patterning of cells and matrix materials in three dimensions, 3D bioprinting enables the recreation of tissue structures that closely mimic their natural counterparts. This capability holds the promise of generating tissue-mimetic constructs capable of replicating the functions of specific tissues within the body.
At our lab, we’ve been exploring a biomimetic approach to 3D bioprinting, which involves mimicking the intricate structure and organization of native tissues. One key aspect of our approach is the utilization of decellularized tissue matrix bioink, which provides a natural scaffold rich in extracellular matrix components necessary for cell adhesion, proliferation, and differentiation.
During my talk, I will delve into the various modalities of bioprinting, each with its unique mechanisms and operations. By discussing the differences between these modalities, attendees will gain a comprehensive understanding of the bioprinting landscape and the specific advantages each technique offers.
Furthermore, I’ll share insights into our ongoing research projects at the lab, particularly focusing on our use of extrusion-based 3D bioprinting. This method allows for precise deposition of bioink materials, enabling the creation of complex tissue constructs with tailored properties.
Moreover, I’ll highlight some of our translational works that are progressing toward clinical trials. These projects represent the culmination of our efforts to bridge the gap between cutting-edge research and real-world applications, with the ultimate goal of developing novel tissue-engineered therapies to address clinical needs.
Join us for an exciting session of Bioprinting Ignited, where two speakers will be selected from the Abstract Submissions, to inspire us with their research. Submit your abstract here to be considered.
Coming soon.
The microenvironments within gingival (gum) tissues play a pivotal role in shaping gingival health, influencing disease progression, treatment outcomes, and systemic diseases. Positioned uniquely at the intersection of hard tissues, microbial flora, and a myriad of external factors such as dietary choices and oral-care products, gingival tissues are central to oral well-being. However, comprehending their intricate functions often poses a challenge due to the significant gap between animal models and simplistic in vitro monolayer cultures.
Recently, we have demonstrated the biofabrication of complex multicellular gingival tissues integrating interstitial fluid flow, epithelial barrier, vasculature, long-term host-microbe co-culture, and innate immune response of gingival tissues to health and disease-associated microbes. Similarly, the flow feature was utilized to emulate the mechanical action of mouth rinse and its role in the assessment of host-material interactions and transmucosal permeation of oral-care formulations in both healthy and diseased states. Lastly, the potential to control spatiotemporal architecture using 3D bioprinting provides opportunities to emulate the spatial variations in architecture and biofabrication of personalized gingival grafts.
In this talk, I will discuss how the enabling features of microphysiological models and 3D bioprinting tools can be utilized to fill the gap and provide new insights into gingival health and disease.
Coming soon.
Bacterial keratitis is a sight-threatening corneal infection caused mainly by Pseudomonas aeruginosa, Staphylococcus aureus, and Streptococcus pneumoniae. The infection spreads quickly and if not treated on time, leads to irreversible corneal damage. Conventional treatment includes administering eye drop formulations. However, frequent application of eye drop leads to patient incompliance, and moreover, poor corneal residence and penetration make the treatment less effective. We have developed contact lenses using two photo-crosslinkable polymers, where the lenses incorporated antimicrobial peptides or tobramycin. The lenses were mucoadhesive and eventually dissolvable without showing any toxicity to the corneal tissues. The patches reduced corneal inflammation and supported damaged corneal healing. The 3D-printing technology could serve as a personalied therapy, where the dose can be manipulated based on the patient’s need. Overall, the technology could serve unmet need as a precision medicine for treating eye infections.
Coming soon.
Desirable bioink properties vary greatly with the bioprinting approach, types of cells, choice of materials, and, most importantly, the specific applications of printed constructs. Our lab is exploring bioprinting for soft and hard tissue regeneration, culturing artificial meat and for designing personalised pharmaceutical products, based on different bioinks with diverse properties.
3D bioprinting enhances 3D tissue culture by enabling a precise control over cellular arrangement, to better replicate the complexity of human organs. We have developed multiple cell-specific bioinks to better recapitulate the native tissue environment for soft (skin) and hard (bone) tissues. Similarly, in the realm of personalized medicines, the development of patient-friendly dosage forms tailored to individual patient’s needs is of paramount importance. Our study has explored the innovative application of tailor-made bioinks to create vegan, low-calorie gummy formulations, optimized for personalized therapy. Through meticulous formulation optimization based on texture and rheological analysis, we have engineered dosage forms that not only meet pharmaceutical standards but also appeal to patients’ preferences.
The talk will focus on requirements of bioinks for such diverse applications and the obstacles faced while optimising different bioprinting parameters to achieve reliable and reproducible materials and products.
Coming soon.
Join world-class experts who are actively developing, validating and promoting non-animal models to define a new gold standard in research, and drive a paradigm shift in safety and efficacy testing. Gain insights into the latest advancements, navigate the challenges, and discover success stories in implementing these innovative models.
Join us for an exciting session of Bioprinting Ignited, where three speakers will be selected from the Abstract Submissions, to inspire us with their research. Submit your abstract here to be considered.
The agenda is subject to change.
Send us an email by filling in the contact form here.
U.S.: +1 (833) 235-5465
EU: +46 31-12 87 00
India: +91 (0) 98808 58741
Japan: +81 (75)746-3032
Singapore: +65 8750 2284
Dr. Bikramjit Basu is a Professor at the Indian Institute of Science, Bangalore, India. He has been pursuing research at the confluence of Materials Science, Biological Science and Medicine. His research group has effectively applied the principles and tools of these disciplines to develop next generation implants and bioengineering solutions to address unmet clinical needs for musculoskeletal, dental, and neurosurgical applications; thereby impacting human healthcare. A Chartered Engineer of the UK, he has the unique distinction of being the only ceramic scientist from India to get elected to all the major international societies and academies, including the World Academy of Ceramics (2023), the European Ceramic Society (2023), the American Ceramic Society (2019). In India, he is the only engineering scientist to get elected as a Fellow of all the National Academies of Engineering, Science and Medicine, including the Indian National Science Academy (2021), Indian Academy of Sciences (2020), American Ceramic Society (2019), National Academy of Medical Sciences (2017), Indian National Academy of Engineering (2015), Society for Biomaterials & Artificial Organs (2014) and National Academy of Sciences, India (2013). Internationally, he is an elected fellow of the International Union of Societies for Biomaterials Science and Engineering (2020), International Academy of Medical and Biological Engineering (2017) and the American Institute of Medical and Biological Engineering (2015). He is a recipient of India’s most prestigious Science and Technology award, Shanti Swarup Bhatnagar Prize (2013) from the Prime Minister of India; and globally competent awards, like Humboldt Research Award from the Alexander von Humboldt foundation (2022), and International Richard Brook Award from the European Ceramic Society (2022). As the current President (2021-24) of the Society for Biomaterials and Artificial Organs India (1000+ members across India, US and Europe) and the Chair of the Bioceramics Division of the American Ceramic Society, ACerS (2022-23), he has brought transformative changes to significantly enhance international visibility of the biomaterials programs in different countries and to bring together key stakeholders (industry professionals and clinicians), while inspiring several hundreds of young researchers in Bioceramics area across the world.
Tim Woodfield is Professor of Regenerative Medicine, Department of Orthopaedic Surgery & Musculoskeletal Medicine at University of Otago Christchurch and Director of the University of Otago Centre for Bioengineering & Nanomedicine. His research involves development of photo-crosslinkable bioinks and bioresins, 3D Bioprinting, spheroid bioassembly and additive manufacturing of medical devices applied to orthopaedics/regenerative medicine. He has >150 publications (h-index: 51) and obtained >NZ$28M in competitive research funding.
He has received a number of prestigious awards including a Rutherford Discovery Fellowship from the Royal Society of New Zealand Te Apärangi and the University of Otago Research Gold Medal. He received the 2020 Research Excellence Award from the Australasian Society for Biomaterials & Tissue Engineering (ASBTE), and was awarded Fellow Biomaterials Science & Engineering (FBSE).
He is the current President of the International Society for Biofabrication, and former President of the Australasian Society for Biomaterials & Tissue Engineering. He is a member of the Tissue Engineering and Regenerative Medicine International Society Asia Pacific Council (TERMIS-AP) and is an Executive Editorial Board member for Biofabrication journal, as well as Editorial Board Member for Advanced Healthcare Materials, APL Bioengineering and Associate Editor for Frontiers in Bioengineering & Biotechnology.
BIOGRAPHY
Dr. Kaushik Chatterjee joined the Indian Institute of Science, Bangalore, in 2011, where he is currently a Professor in the Department of Materials Engineering and the Department of Bioengineering. His research group focuses on materials for biomedical applications. Specifically, they are using 3D printing and additive manufacturing technologies to prepare medical devices and tissue scaffolds.
Prof. Biman B. Mandal is a Professor in the Department of Biosciences and Bioengineering, School of Health Science and Engineering and Centre for Nanotechnology, IIT Guwahati. Due to his seminal contributions to the field of Biomaterials, Tissue Engineering and 3D Organ Bioprinting, Prof. Mandal is included as one of the “75 under 50 Scientists shaping today’s India” a list prepared by DST, Govt. of India. He is included in “World Top 2% Scientist List” prepared by Stanford University USA. Prof. Mandal is an Associate Editor of ACS Biomaterials Science and Engineering and Editorial Board member of 10 International high impact Journals. He was the President of STERMI (Society for Tissue Engineering and Regenerative Medicine India) 2021-2024.
Prof. Mandal has published more than 190 research articles with over 11,600+ citations and has an H-index of 60. He has 23 patents and licensed 05 healthcare technologies to Industry with 01 product already in market. Prof. Mandal has bagged prestigious Young scientist awards from the Indian National Academy of Sciences (INSA) and National Academy of Sciences India (NASI). He has won NASI-SCOPUS Young Scientist award for his high citations and B. M. BIRLA Science Prize in Biology along with 06 other prestigious young scientist awards. Recently he has been awarded the prestigious SWARNAJAYANTI Fellowship & S. RAMACHANDRAN National Bioscience Award by DST and DBT in Life Sciences for the year 2020-2021.
Neetu Singh obtained her Bachelors and Masters degrees from University of Mumbai and her doctoral degree in chemistry from Georgia Institute of Technology, Atlanta, USA. She obtained her postdoctoral training at the Harvard-MIT Division of Health Sciences and Technology, USA.
Prof. Singh returned to India and joined IIT Delhi as an Assistant Professor in the Center for Biomedical Engineering in 2014.
In her current program at IITD, she is establishing a research program that explores systematic probing into nanomaterials biological activity and formulates “design rules” for developing nanosystem for specific bio-medical & healthcare applications. Her group at IIT Delhi is integrating concepts and skills from chemistry, materials science, and biology to design nano-structured materials with enhanced functionalities for applications in biomedical implants, disease diagnostics, tissue engineering and regenerative medicine.
Her scientific contribution has been recognized by several awards and honors. She is the recipient of “Innovative Young Biotechnologist award 2013” by Department of Biotechnology (DBT), India. In 2019, she received the Veena Arora young researcher award by IIT Delhi, which recognizes best research contributions at IIT Delhi by faculty below 40 years. She is the receipt of NASI-SCOPUS young Scientist award for “Women-in Science”-2019; DBT’s Janaki Ammal Young scientist -2021 and Science and Engineering Research Board (SERB)-India, POWER Fellow 2021. She is also a mentor for an IITD start-up, “Kriya-Labs”, that is bringing valorization to agro waste by technological solutions.
She is also an editorial advisory board member of the journal Bioconjugate Chemistry (a pioneering publication of American Chemical Society) and a new Springer journal – In Vitro Models.
Dr. Baiju G Nair is an Associate Professor and Head of the Department of Bioscience and Engineering at NIT Calicut, where he leads the Functional Materials and Tissue Engineering Laboratory. His academic journey began with an MS and Doctor of Engineering in Bionanofusion Technology as a MEXT fellow in Japan, showcasing his dedication to pioneering research.
After completing his doctoral degree, Dr. Nair was honored with the prestigious JSPS fellowship at Riken, Japan, in 2012, followed by recognition through the SPDR program for young scientists in 2014. His commitment to excellence was further acknowledged in 2023 with the Bridge Fellowship by JSPS.
Dr. Nair is renowned for his prolific research contributions, evident through numerous peer-reviewed articles, books, and secured patents in his specialized domains. His outstanding achievements include receiving the Young Scientist Award from the Biomedical Engineering Forum in Japan in 2017 and the Best Research Award at Nanocon in the Czech Republic in 2011.
His research interests encompass a broad spectrum, ranging from tissue engineering and 3D & 4D bioprinting to biomaterials, DNA and RNA nanotechnology, and exploring small molecules from extremophiles. Dr. Nair’s innovative work enriches the scientific community and promises groundbreaking advancements in healthcare and biotechnology.
Dr. Falguni Pati, currently an Associate Professor and the Head of the Department of Biomedical Engineering at IIT Hyderabad, boasts an impressive academic and research background. He obtained his Ph.D. from IIT Kharagpur and gained valuable experience through postdoctoral appointments at POSTECH, South Korea, and KTH, Sweden, before joining IITH in 2015. Dr. Pati leads the Biofabrication and Tissue Engineering (BioFabTE) Lab at IITH, where the primary focus lies in advancing tissue engineering through 3D bioprinting technology. His lab endeavors to develop innovative tissue-engineered products and in vitro tissue/organ models, with a keen interest in bioinks, bioprinting methods, and technologies to produce tissue analogs-on-demand. Dr. Pati’s contributions extend beyond research into academia. He designed and implemented a pioneering course on Biofabrication for undergraduate and postgraduate students at IITH, the first of its kind in India. Additionally, he has been teaching the course “Organ Printing” on NPTEL for the last three years, further disseminating knowledge in this specialized domain.
Recognition for his impactful work includes the prestigious Ramalingaswami fellowship awarded to him in 2016. Dr. Pati’s research endeavors have been supported by various funding agencies such as DST-SERB, DBT, ICMR, and MoE, underscoring the significance and relevance of his research initiatives.
Notably, in 2022, Dr. Pati’s team achieved a significant milestone by securing the Sree Ramakrishna Paramahamsa Research Grant worth 3 Cr in Biomedical Sciences. This grant was awarded for the clinical trial of their biomimetic hydrogel, showcasing the potential impact of their research in addressing blinding corneal diseases.
Dr. Gopu Sriram is a tenure-track Assistant Professor at the Faculty of Dentistry, and Department of Biomedical Engineering, National University of Singapore. He also serves as the Co-Thrust Lead at the NUS Centre for Additive Manufacturing, where he directs the utilization of 3D printing, biofabrication, and additive manufacturing technologies for applications in oral and craniofacial healthcare.
Dr. Sriram leads the Tissue Mimetics Laboratory, where his team’s research focuses on the application and convergence of microfluidics, 3D organotypic cultures, and 3D printing-based biofabrication technologies for dental applications. Through the application of these technologies, his team develops animal alternative models to explore host-microbiome-material interactions in periodontal (gum) disease and advance the regeneration of dental, oral, and craniofacial tissues.
Dr. Sriram and his mentees have garnered numerous accolades in recognition of their outstanding contributions to dental research, animal alternatives and excellence in teaching. Furthermore, some of his research has translated to the establishment of a Singapore-based startup dedicated to the creation of 4D barrier tissue models for cruelty-free testing of consumer-care products.
BIOGRAPHY
Janani Radhakrishnan is a scientist at the National Institute of Animal Biotechnology, Hyderabad. She pursued her PhD in tissue engineering, at the School of Chemical and Biotechnology, SASTRA University, Thanjavur, as a DST INSPIRE research fellow. She joined as a postdoctoral fellow at Indian Institute of Technology Madras (IITM), Chennai and worked on 3D bioprinting functional tissue constructs. Further, she was awarded the INSPIRE faculty fellowship and worked at CSIR – Central Leather Research Institute (CLRI), Chennai. Her
research interests include 3D biofabrication of tissue mimetic constructs using injectable hydrogels and 3D bioprinting for regenerative and organotypic constructs. In addition to her publications in premier international journals, she has been granted two Indian patents. Recently, she has been selected for the paired early career fellowship in applied research (PECFAR) by Indo-German Science & Technology Centre (IGSTC), to collaborate with Ruhr university, Germany on developing functional bone model.
Prof. Swati Biswas completed B. Pharm and M. Pharm from Jadavpur University. After serving as a lecturer in a pharmacy College in Sikkim for a brief period, Prof. Biswas moved to the USA in 2003 to join the Department of Pharmaceutical Sciences at Wayne State University, Detroit, Michigan, USA as a research fellow. She received the prestigious Thomas C. Rumble fellowship to join the doctoral program. After completing her doctoral study in 2008, she joined the same lab as a postdoctoral fellow and, after one year, joined as a postdoctoral research associate in the Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, Massachusettes.
The zeal to work vigorously on research ideas made her choose academia as the career option. Prof. Biswas started her independent research career as an Assistant Professor at BITS Pilani, Hyderabad (India), after moving to India in 2013. In 2018, she was promoted to Associate Professor, and last year, she was promoted to professor in the Department of Pharmacy.
Prof. Biswas received the honor of serving as an Editorial Advisory Board member of the journal published by the American Chemical Society, Molecular Pharmaceutics (2022-2023). She was a guest editor of their Asia-specific issue, “Advances in Molecular Pharmaceutical Research from Asia. The journal published an interview-based article about her scientific journey titled “Voices in Molecular Pharmaceutics: Meet Dr. Swati Biswas, an Academic Developing Therapeutic Weapons to Kill Cancer Cells”. She is the associate editor of the journal, Frontiers in Biomaterials Sciences in the specialty section of Delivery Systems and Controlled Release. She received the DBT-Bio-CARe award in 2013 and travel grant from ICMR.
Prof. Biswas has 115 publications and 13 Indian and 2 US patents. She has written 12 book chapters and presented papers in 112 conferences. Prof. Biswas has five ongoing projects in the lab. She has a total of 6087 citations, h-index. 37, and an i-10 index of 74, as per the Google Scholar report. She is supervising 8 PhD students currently in her lab. The lab has been generously funded by DST, DBT, ICMR, IISC, CSIR, Sun Pharmaceutical Advanced Research Company, Daewoong Pharmaceuticals, Dr. Reddy’s Lab, and Hetero Labs, Hyderabad.
Prof. Biswas has been working in nanomedicine research for the last fifteen years. She has been in the list of 2 % of scientists in the single-years from 2019-2022 in Pharmacology and Pharmacy/Nanoscience & nanotechnology/ Clinical Medicine. Professor Swati Biswas was enlisted as a highly cited researcher in 2022 by Clarivate, where the database included only 6,938 researchers worldwide, demonstrating significant contribution in publishing papers that rank in the top of 1 % by citations.
BIOGRAPHY
Dr. Indranil Banerjee is an associate professor in the department of Bioscience and Bioengineering, Indian Institute of Technology, Jodhpur. He has been working in the field of biomaterial and tissue engineering for the last 14 years. He did his double bachelors (B.Sc in Chemistry (Hons) and B.Tech in Chemical Technology) and Masters (M.Tech. in Pharmaceutical and Fine Chemical Technology) from the University of Calcutta. Later, he pursued his PhD in Biotechnology from the Indian Institute of Technology, Kharagpur. He started his academic career as an assistant professor in the department of Biotechnology and Medical Engineering, National Institute of Technology Rourkela. He was invited as a guest scientist to the Max Planck Institute of Intelligent Systems, Stuttgart, Germany. He is an associate editor of Frontiers in Medical Technology (Medtech data analytics). He has so far authored more than 100 research articles and book chapters altogether and edited a number of books.
BIOGRAPHY
Dr. Sumit Murab is an Assistant Professor in the School of Biosciences & Bioengineering at Indian Institute of Technology (IIT) Mandi. He also holds secondary appointments in the BioX Centre, Advanced Materials Research Centre (AMRC), Indian Knowledge System and Mental Health Applications Centre (IKSMHA) and Technology Innovation Hub in Human-Computer Interaction (iHub) at IIT Mandi. He is the Coordinator of the Undergraduate Program in Bioengineering and is the Director of the Translational Tissue Engineering Lab at IIT Mandi. His research interests includes 3D bioprinting, orthopaedic tissue engineering, regenerative medicine, in vitro disease models, and bioinspired materials.
BIOGRAPHY
Dr. Charu Chandrasekera is the founder and executive director of Canada’s national hub and the international interface dedicated exclusively to animal-free methods, the Canadian Centre for Alternatives to Animal Methods. She is an experienced biomedical scientist, a former animal researcher, a science policy expert, and an animal lover. Through multidisciplinary partnerships among diverse stakeholders, Dr. Chandrasekera promotes the replacement of animals in Canadian biomedical research, education, and regulatory testing through 21st century science, innovation, and ethics.